Drugs for Cough Variant Asthma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 31)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Procaterol |
Approved, Investigational |
Phase 4 |
|
72332-33-3 |
688561 |
Synonyms:
(R*,s*)-(+-)-8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone
(R*,S*)-(+-)-8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone
5-[1-hydroxy-2-(propan-2-ylamino)butyl]quinoline-2,8-diol
60443-17-6
62929-91-3 (mono-hydrochloride)
72332-33-3
8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone
8-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one
AC-13705
AC1L1J8G
AC1Q6I3X
AR-1J3938
BRD-A22684332-003-02-3
BSPBio_003239
CHEMBL160519
CI-888
CID4916
D08424
EINECS 276-590-0
Hydrochloride, procaterol
KBio3_002739
L023776
LS-142797
Meptin
Meptin (TN)
MolPort-005-934-511
Monohydrochloride, procaterol
NSC 308904
NSC308904
|
OPC-2009
Pro air
Pro-air
ProAir
Pro-Air
Procaterol
PROCATEROL
Procaterol (INN)
Procaterol [INN:BAN]
Procaterol hydrochloride
Procaterol monohydrochloride
Procaterol Monohydrochloride
Procaterol monohydrochloride, (r*,r*)-(-)-isomer
Procaterol monohydrochloride, (r*,r*)-(+)-isomer
Procaterol monohydrochloride, (r*,r*)-(+-)-isomer
Procaterol monohydrochloride, (r*,s*)-(-)-isomer
Procaterol monohydrochloride, (r*,s*)-(+)-isomer
Procaterol, (r*,r*)-(+-)-isomer
Procaterol, (r*,s*)-(-)-isomer
Procaterolo
Procaterolo [DCIT]
Procaterolum
Procaterolum [INN-Latin]
Procaterolum [Latin]
SPBio_001400
Spectrum2_001550
Spectrum3_001770
STK632659
|
|
2 |
|
Montelukast |
Approved |
Phase 4 |
|
158966-92-8 |
5281040 |
Synonyms:
(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetate
(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetate
1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulphanyl]methyl]cyclopropaneacetate
1-[[[(1 R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulphanyl]methyl]cyclopropaneacetic acid
151767-02-1 (sodium)
158966-92-8
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
AC1NQXXW
Apxi toxin
BIDD:GT0394
Brondilat
Brondilat (TN)
C07482
C35H36ClNO3S
Cahill may roberts brand OF montelukast sodium
CHEBI:50730
CHEMBL787
CID5281040
|
D08229
DB00471
HMS2089D07
HSDB 7582
LS-173539
Merck brand OF montelukast sodium
Merck frosst brand OF montelukast sodium
Merck sharp and dohme brand OF montelukast sodium
MK 0476
MK-0476
Montair
montelukast
Montelukast
Montélukast
Montelukast (INN)
Montelukast [INN:BAN]
Montelukast sodium
Montelukastum
Singulair
Singular
sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
Sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
UNII-MHM278SD3E
|
|
3 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
Aresol
Benylin-e
Breonesin
Bronchol
Ether, guaiacol glyceryl
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
|
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesina
Guaifenesine
guaiphenesin
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
Humibid
Hustosil
Hytuss
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
|
|
4 |
|
Budesonide |
Approved |
Phase 4 |
|
51333-22-3 |
63006 5281004 |
Synonyms:
(11b,16a)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11β,16α)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11Β,16α)-16,17-(butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
AC-4697
B 7777
B7777_SIGMA
Bidien
Bio-0010
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Budecort Inhaler
Budenofalk
Budeson
Budesónida
budesonide
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide [USAN:INN:BAN:JAN]
Budesonide Easyhaler
Budesonide MMX
Budesonide, (R)-isomer
Budesonide, (S)-isomer
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
Cortivent
CPD000058337
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
Entocort
Entocort ec
Entocort EC
Entocort EC (TN)
EU-0100174
Giona Easyhaler
HMS1569H17
|
HMS1921I22
HMS2094I13
HMS501H17
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
Lopac0_000174
LS-187734
LS-7235
MAP-0010
Micronyl
Miflonide
MLS000028507
MLS001077323
MLS002207112
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick_840
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort turbuhaler
Pulmicort Turbuhaler
Respules
Rhinocort
Rhinocort alpha
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S1286_Selleck
S-1320
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
ST51039033
TL8003397
Tridesilon
Uceris
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
|
|
5 |
|
Bambuterol |
Investigational |
Phase 4 |
|
81732-65-2, 81732-46-9 |
54766 |
Synonyms:
(+-)-5-(2-(tert-Butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)
(+-)-5-(2-(Tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)
(+-)-5-(2-(Tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamic acid)
(±)-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)
[3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate
5-(2-(tert-butylamino)-1-hydroxyethyl)-3-phenylene bis(dimethylcarbamate)
5-(2-(Tert-butylamino)-1-hydroxyethyl)-3-phenylene bis(dimethylcarbamate)
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diyl bis(dimethylcarbamate)
81732-65-2
AC1L1HP6
AC1Q60S0
Bambec
Bambuterol
bambutérol
Bambuterol (INN)
Bambuterol [BAN:INN]
Bambuterol hydrochloride
Bambuterolum
Bambuterolum [Latin]
BPBio1_000531
BRD-A17462676-003-03-3
BSPBio_000481
C18H29N3O5
CHEBI:553827
CHEMBL521589
|
CID54766
D07377
DB01408
HMS2089J18
KWD-2183
L004435
LS-49501
MLS002153785
MolPort-003-844-685
NCGC00179546-01
Oxeol
Prestwick0_000361
Prestwick1_000361
Prestwick2_000361
Prestwick3_000361
SMR001233168
SPBio_002402
STK643808
terbutaline bis(dimethylcarbamate)
Terbutaline bis(dimethylcarbamate)
Terbutaline bis(dimethylcarbamic acid)
terbutaline bisdimethylcarbamate
Terbutaline bisdimethylcarbamate
Terbutaline bisdimethylcarbamic acid
UNII-Y1850G1OVC
|
|
6 |
|
Sympathomimetics |
|
Phase 4 |
|
|
|
7 |
|
Leukotriene Antagonists |
|
Phase 4 |
|
|
|
8 |
|
Budesonide, Formoterol Fumarate Drug Combination |
|
Phase 4 |
|
|
|
9 |
|
Antitussive Agents |
|
Phase 4 |
|
|
|
10 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 4 |
|
|
|
11 |
|
Anti-Asthmatic Agents |
|
Phase 4 |
|
|
|
12 |
|
Bronchodilator Agents |
|
Phase 4 |
|
|
|
13 |
|
Adrenergic beta-Agonists |
|
Phase 4 |
|
|
|
14 |
|
glucocorticoids |
|
Phase 4 |
|
|
|
15 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
16 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
17 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
18 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
19 |
|
Hormones |
|
Phase 4 |
|
|
|
20 |
|
Formoterol Fumarate |
|
Phase 4 |
|
|
|
21 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
22 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
23 |
|
Methacholine Chloride |
|
Phase 4 |
|
|
|
24 |
|
Muscarinic Agonists |
|
Phase 4 |
|
|
|
25 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
26 |
|
Nitric Oxide |
Approved |
|
|
10102-43-9 |
145068 |
Synonyms:
(.)NO
(NO)(.)
[NO]
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous nitrate vasodilator
Endogenous Nitrate Vasodilator
Endothelium-derived nitric oxide
Endothelium-Derived Nitric Oxide
endothelium-derived relaxing factor
Endothelium-derived relaxing factor
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, mononitrogen
Monoxide, Mononitrogen
Monoxide, nitrogen
Monoxide, Nitrogen
monoxido de nitrogeno
Monoxido de nitrogeno
Monóxido de nitrógeno
monoxyde d'azote
Monoxyde d'azote
Nitrate vasodilator, endogenous
Nitrate Vasodilator, Endogenous
nitric oxide
|
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, endothelium derived
Nitric Oxide, Endothelium Derived
Nitric oxide, endothelium-derived
Nitric Oxide, Endothelium-Derived
NITRIC-OXIDE
nitrogen monooxide
Nitrogen monooxide
nitrogen monoxide
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
nitrosyl
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
NO(.)
OHM 11771
Oxide, nitric
Oxide, Nitric
oxido de nitrogeno(II)
Oxido de nitrogeno(II)
óxido de nitrógeno(II)
oxido nitrico
Oxido nitrico
óxido nítrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, endogenous nitrate
Vasodilator, Endogenous Nitrate
|
|
27 |
|
Fenofibrate |
Approved |
|
|
49562-28-9 |
3339 |
Synonyms:
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoate 1-methylethyl ester
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester
49562-28-9
AB00052196
Abbott brand OF procetofen
Abbott Brand of Procetofen
AbZ brand OF procetofen
AbZ Brand of Procetofen
AC1L1FPK
AC-4227
AKOS005107777
Aliud brand OF procetofen
Aliud Brand of Procetofen
Ankebin
Antara
Antara (micronized)
Antara (TN)
Antara micronized procetofen
Antara Micronized Procetofen
Anto brand OF procetofen
Anto Brand of Procetofen
Apo feno micro
Apo Feno Micro
Apo fenofibrate
Apo Fenofibrate
Apo-fenofibrate
Apo-Fenofibrate
Apo-feno-micro
Apo-Feno-Micro
Apotex brand OF procetofen
Apotex Brand of Procetofen
AZU, fenofibrat
AZU, Fenofibrat
Azupharma brand OF procetofen
Azupharma Brand of Procetofen
betapharm Brand of Procetofen
Betapharm brand OF procetofen
BIDD:GT0574
Bouchara brand OF procetofen
Bouchara Brand of Procetofen
BPBio1_000166
BRD-K50388907-001-05-6
BRN 2062462
BSPBio_000150
BSPBio_003162
C07586
C20H21ClO4
CAS-49562-28-9
CCRIS 7282
CHEBI:5001
CHEMBL672
CID3339
CiL
CIP-Fenofibrate
Controlip
CPD000058299
ct Arzneimittel Brand of Procetofen
CT Arzneimittel brand OF procetofen
ct-Arzneimittel Brand of Procetofen
CT-Arzneimittel brand OF procetofen
D00565
D011345
DB01039
Debat, Fenofibrate
Debat, fénofibrate
DivK1c_000557
durafenat
Durafenat
EINECS 256-376-3
Elasterate
Elasterin
EU-0100486
F 6020
F6020_SIGMA
Fenobeta
Fenobrate
Fenofanton
Fenofibrat abz
Fenofibrat AbZ
Fenofibrat al
Fenofibrat AL
Fenofibrat azu
Fenofibrat AZU
Fenofibrat FPh
Fenofibrat FPH
Fenofibrat heumann
Fenofibrat Heumann
Fenofibrat hexal
Fenofibrat Hexal
Fenofibrat ratiopharm
Fenofibrat stada
Fenofibrat Stada
fenofibrat von ct
Fenofibrat von CT
fenofibrate
Fenofibrate
Fenofibrate (JAN/INN)
FENOFIBRATE (MICRONIZED)
Fenofibrate [INN:BAN]
Fenofibrate Debat
Fénofibrate debat
Fenofibrate IDD-P
Fenofibrate MSD
Fénofibrate MSD
Fenofibrato
Fenofibrato [INN-Spanish]
Fenofibrat-ratiopharm
Fenofibratum
Fenofibratum [INN-Latin]
fenofibric acid
Fenofibric acid
Fenogal
Fenoglide
Fenomax
Fenotard
Finofibrate
Finofibric acid
FNF
Fournier brand OF procetofen
Fournier Brand of Procetofen
Fulcro
gate Brand OF procetofen
Gate Brand of Procetofen
Gen fenofibrate
Gen Fenofibrate
Gen-fenofibrate
Gen-Fenofibrate
Genpharm brand OF procetofen
Genpharm Brand of Procetofen
GNR Pharma brand OF procetofen
GNR Pharma Brand of Procetofen
GNR-Pharma brand OF procetofen
GNR-Pharma Brand of Procetofen
GRS-027
Heumann brand OF procetofen
Heumann Brand of Procetofen
Heumann, fenofibrat
Heumann, Fenofibrat
Hexal brand OF procetofen
Hexal Brand of Procetofen
Hexal, fenofibrat
Hexal, Fenofibrat
HMS1568H12
HMS1921B17
HMS2090G20
HMS2092B05
HMS501L19
I06-0048
IDI1_000557
Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate
Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionic acid
Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate
|
Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionic acid
Isopropyl 2-(p-(p-chlorobenzoyl)phenoxy)-2-methylpropionate
isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate
KBio1_000557
KBio2_001730
KBio2_004298
KBio2_006866
KBio3_002382
KBioGR_000706
KBioSS_001730
Knoll brand OF procetofen
Knoll Brand of Procetofen
LCP-Feno
LCP-FenoChol
LF 178
LF178
LF-178
Lichtenstein brand OF procetofen
Lichtenstein Brand of Procetofen
Lipanthyl
Lipantil
Lipantil (TN)
Liparison
Lipidex
Lipidil
Lipidil Micro
Lipidil Supra
Lipidil ter
Lipidil Ter
Lipidil-ter
Lipidil-Ter
Lipifen
Lipirex
Lipoclar
Lipofen
Lipofen (TN)
Lipofene
Liposit
Lipsin
Livesan
Lofibra
Lopac0_000486
Lopac-F-6020
LS-121256
Luxacor
Merck dura brand OF procetofen
Merck dura Brand of Procetofen
Micronized procetofen, antara
Micronized Procetofen, Antara
MLS000028515
MLS001148191
MolPort-002-887-051
MTW Brand of Procetofen
MTW Brand OF procetofen
MTW Fenofibrat
MTW-Fenofibrat
NCGC00015437-01
NCGC00015437-02
NCGC00015437-03
NCGC00015437-06
NCGC00015437-12
NCGC00021475-03
NCGC00021475-04
NCGC00021475-05
NCGC00021475-06
NCGC00021475-07
NCGC00021475-08
nchembio790-comp24
NINDS_000557
Nolipax
Normalip
Novartis brand OF procetofen
Novartis Brand of Procetofen
Novo fenofibrate
Novo Fenofibrate
Novo-fenofibrate
Novo-Fenofibrate
Novopharm brand OF procetofen
Novopharm Brand of Procetofen
NSC 281319
NSC281319
Nu fenofibrate
Nu Fenofibrate
Nu pharm brand OF procetofen
Nu Pharm Brand of Procetofen
Nu-fenofibrate
Nu-Fenofibrate
Nu-pharm brand OF procetofen
Nu-Pharm Brand of Procetofen
Pharmascience brand OF procetofen
Pharmascience Brand of Procetofen
Pharmavit
Phenofibrate
PMS Fenofibrate micro
PMS Fenofibrate Micro
PMS-Fenofibrate micro
PMS-Fenofibrate Micro
Prestwick_217
Prestwick0_000275
Prestwick1_000275
Prestwick2_000275
Prestwick3_000275
Procetofen
Procetofen reliant brand
Procetofen Reliant Brand
Procetofen, antara micronized
Procetofen, Antara Micronized
Procetofene
Proctofene
Protolipan
Q Pharm brand OF procetofen
Q Pharm Brand of Procetofen
Q-Pharm brand OF procetofen
Q-Pharm Brand of Procetofen
ratiopharm Brand of Procetofen
Ratiopharm brand OF procetofen
Reliant brand OF procetofen
Reliant Brand of Procetofen
S1794_Selleck
SAM002264613
Schering plough brand OF procetofen
Schering Plough Brand of Procetofen
Schering-plough brand OF procetofen
Schering-Plough Brand of Procetofen
Secalip
Sedufen
SMR000058299
SPBio_001380
SPBio_002369
Spectrum_001250
SPECTRUM1501010
Spectrum2_001390
Spectrum3_001431
Spectrum4_000413
Spectrum5_001479
ST085313
Stada, fenofibrat
Stada, Fenofibrat
Stadapharm brand OF procetofen
Stadapharm Brand of Procetofen
Supralip
TL8003296
Tricor
TRICOR (MICRONIZED)
Tricor (TN)
Triglide
Triglide (TN)
Trilipix
UNII-U202363UOS
United drug brand OF procetofen
United Drug Brand of Procetofen
ZINC00584092
|
|
28 |
|
Protective Agents |
|
|
|
|
|
29 |
|
Antioxidants |
|
|
|
|
|
30 |
|
Vasodilator Agents |
|
|
|
|
|
31 |
|
Endothelium-Dependent Relaxing Factors |
|
|
|
|
|
Interventional clinical trials:
(show all 12)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Randomised, Open-label, Parallel-group Study of the Response to Bronchodilator Treatment in Subjects With Eosinophilic Bronchitis and the Mechanism of Varied Responses to Bronchodilator Treatment. |
Unknown status |
NCT02002754 |
Phase 4 |
Bambuterol Hydrochloride tablets |
2 |
A Multicentered, Double-blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Procaterol Hydrochloride With Inhaled Glucocorticoid in Treatment Patients With Cough Variant Asthma (CVA) |
Unknown status |
NCT01170429 |
Phase 4 |
Procaterol hydrochloride;Meptin placebo |
3 |
Randomised, Open-label, Parallel-group Study of Therapeutic Effect of Leukotriene Modulator Montelukast Alone or Combined With Inhaled Corticosteroid on Cough Variant Asthma |
Unknown status |
NCT01404013 |
Phase 4 |
ICS/LABA;Montelukast;ICS/LABA and Montelukast |
4 |
Randomised, Double-blinded, Placebo-Controlled Study of Therapeutic Effect of Su-Huang Antitussive Capsule on Cough Variant Asthma(CVA) |
Unknown status |
NCT01584804 |
Phase 4 |
Su-Huang antitussive capsule;Sugar pill |
5 |
Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients |
Unknown status |
NCT02934945 |
Phase 4 |
budesonide 160μg/formoterol 4.5μg |
6 |
The Efficacy of Budesonide/Formoterol in Cough Variant Asthma -- A Multi-center Randomized, Controlled Clinical Trial |
Recruiting |
NCT04171180 |
Phase 4 |
budesonide/formoterol |
7 |
Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Hypertonic Saline in Individuals With Cough Variant Asthma and Chronic Cough |
Not yet recruiting |
NCT03105843 |
Phase 4 |
Methacholine (MCh) Challenge Testing |
8 |
Observation of the Respiratory Impedance and Inflammation in Cough Variant Asthma Patients Treated in Combination of Chanqin Granules. |
Unknown status |
NCT03319043 |
Phase 1, Phase 2 |
Chanqin granules |
9 |
Evaluating the Efficacy of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma |
Unknown status |
NCT03573284 |
|
|
10 |
Difference in Gene Expression Profile in Peripheral Blood Mononuclear Cells and Inflammation Profile in Patients With Classic Asthma, Cough Variant Asthma, and Eosinophilic Bronchitis Compared With Healthy Controls |
Unknown status |
NCT02555345 |
|
|
11 |
A Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Patient Aged 5-Year Old or Younger in Outpatient Department |
Completed |
NCT00660114 |
|
|
12 |
Bronchodilating and Bronchoprotective Effects of Deep Inspirations in Asthma, Cough Variant Asthma and Chronic Cough With Normal Airway Sensitivity and Sensory-Mechanical Responses to High-Dose Methacholine in Healthy Normal Subjects |
Completed |
NCT01659476 |
|
|
|